United States Federal Circuit
AMGEN, INC. v. HOECHST MARION ROUSSEL, INC., 01-1191/1218
In patent claims related to the production of a hormone that controls the formation of red blood cells in bone marrow, the district court's determination that none of the patents in suit is unenforceable for inequitable conduct is affirmed, but the court committed errors of law in certain of its validity and infringement determinations.
Appellate Information
- Decided 01/06/2003
- Published 01/06/2003
Judges
Court
- United States Federal Circuit